Prolonged QT Interval on ECG with Chest Heaviness

This is a clinically urgent combination. Chest heaviness together with a prolonged QT raises the possibility of acute myocardial ischemia as both the cause of the QT prolongation and as an independent emergency. The risk is life-threatening arrhythmia - particularly torsades de pointes (TdP) and ventricular fibrillation.

Understanding the QT Interval

The QT interval represents the total period of ventricular electrical activity - from depolarization (start of QRS) to the end of repolarization (end of T wave). The heart rate strongly influences it, so the corrected QT (QTc) using Bazett's formula must always be calculated:

QTc = QT / √(R-R interval)

Normal QTc values (Tintinalli's Emergency Medicine):

Adult males: ≤ 440 ms
Adult females: ≤ 460 ms
Risk threshold: QTc > 480-499 ms = moderate risk; QTc > 500 ms = significantly elevated risk of torsades

ECG example of a prolonged QT interval (QTc = 550 ms):

Long QT interval ECG showing QTc of 550 milliseconds

Why Does Chest Heaviness + Prolonged QT Matter?

Myocardial ischemia is a recognized acquired cause of QT prolongation. From multiple authoritative sources (Ganong's Physiology, Tintinalli's, Braunwald's):

"Long QT syndrome can be caused by a number of different drugs, by electrolyte abnormalities, and by myocardial ischemia." - Ganong's Review of Medical Physiology

"Acquired long QT syndrome can occur from electrolyte abnormalities, medication effects, and other disease states, such as acute coronary syndrome and severe left ventricular dysfunction." - Tintinalli's Emergency Medicine

A patient presenting with chest heaviness must therefore be evaluated for ACS first. QT prolongation in this context may be a secondary ECG marker of ongoing ischemia.

Causes of Prolonged QT (Differential Diagnosis)

Category	Examples
Ischemia / Cardiac	Acute coronary syndrome, myocarditis, severe LV dysfunction
Electrolyte disorders	Hypokalemia, hypomagnesemia, hypocalcemia
Drugs	Procainamide, quinidine, erythromycin, azole antifungals, tricyclic antidepressants, phenothiazines, class IA/IC antiarrhythmics, organophosphates
Congenital syndromes	Romano-Ward syndrome, Jervell-Lange-Nielsen syndrome (+ congenital deafness)
Other	Hypothyroidism, anorexia nervosa, psychotropic medications

Rosen's Emergency Medicine, p. 1991-1996
Tintinalli's Emergency Medicine, p. 2271

The Main Arrhythmic Danger: Torsades de Pointes

Torsades de pointes (TdP) is a polymorphic ventricular tachycardia that occurs in the setting of prolonged QT. Its defining features (Rosen's EM):

Ventricular rate > 200 bpm
Undulating ("twisting") QRS axis - polarity of complexes shifts around the baseline
Paroxysms typically < 90 seconds (but can degenerate into VF)

Women are at greater risk. Acquired TdP is much more common than congenital and is pause-dependent (triggered by slow heart rate). Common triggers: hypokalemia, hypomagnesemia, and QT-prolonging drugs - especially in combination.

ECG of ventricular tachycardia (including intermittent/nonsustained forms):

Ventricular tachycardia ECG tracings showing AV dissociation

Clinical Features to Elicit

In a patient with chest heaviness + long QT, ask about:

Palpitations, syncope, dizziness, near-faints - suggestive of VT episodes
Exertional symptoms - congenital LQTS; ischemia
Family history of sudden unexplained death, cardiac disease, or congenital deafness
Drug history - any new medications (especially antibiotics, antipsychotics, antiarrhythmics)
Recent diarrhea/vomiting - electrolyte depletion

Schwartz Scoring for Congenital LQTS (if ACS excluded)

Feature	Points
QTc ≥ 480 ms	3
QTc 460-479 ms	2
QTc 450-459 ms (male)	1
T-wave alternans	1
Notched T waves in ≥ 3 leads	1
Syncope (stress-provoked)	2
Syncope (not stress-provoked)	1
Family history of LQTS	1
Family history of sudden death < 30 y	0.5

Score ≥ 3.5 = high probability of congenital LQTS.

Immediate Management

Priority 1: Rule Out ACS

12-lead ECG, serial troponins, continuous monitoring
Look for ST changes, new Q waves, T-wave inversions alongside the long QT
Do NOT give QT-prolonging drugs (e.g., azithromycin, ondansetron) pending workup

For Torsades de Pointes (Rosen's EM / Tintinalli's):

Situation	Treatment
Stable, acquired TdP	IV Magnesium sulfate 1-2 g IV push (even without hypomagnesemia)
Electrolyte abnormalities	Correct K+, Mg2+, Ca2+
Heart rate too slow	Overdrive pacing OR isoproterenol infusion (raise rate to 100-120 bpm) to shorten repolarization
Unstable / sustained TdP	Electrical cardioversion (synchronization may not be possible)
Congenital LQTS	Beta-blockers (reduce sympathetic triggers)

Drugs to AVOID:

Class IA antiarrhythmics: procainamide, quinidine, disopyramide
Class IC agents
Amiodarone (if TdP-related)
Any further QT-prolonging medication

"Lidocaine is the safest medication for patients with prolonged QT interval-induced ventricular tachycardia or fibrillation." - Rosen's Emergency Medicine

Long-Term Management

Congenital LQTS: Beta-blockers (first-line); pacemaker or ICD for refractory cases
Acquired LQTS: Remove the offending drug/cause; correct electrolytes; avoid recurrence
Refer to cardiology / electrophysiology
Restrict competitive sports in all patients with diagnosed LQTS
Patient education: avoid QT-prolonging drugs (check CredibleMeds)

Bottom line: Chest heaviness + prolonged QT is a red flag presentation. Treat it as a potential ACS first, immediately correct any electrolyte abnormalities, stop all QT-prolonging drugs, have magnesium sulfate at bedside, and monitor continuously. If TdP occurs, IV magnesium and overdrive pacing are the primary interventions.

Rosen's Emergency Medicine, pp. 1996-2000; 2402-2426
Tintinalli's Emergency Medicine, pp. 2271-2282
Ganong's Review of Medical Physiology, p. 533
Roberts & Hedges' Clinical Procedures in Emergency Medicine, pp. 4400-4406

This is a shared conversation. Sign in to Orris to start your own chat.